Priced for a smaller company: management is quietly telling investors the business has already outgrown what the numbers
The model's full reasoning — Q4 2023 call → NOWe need to determine if management conveys that outsiders are currently underweighting something the company has already done, and points to a concrete, already-completed/operating piece of the business whose contribution is still ahead. Let's analyze the transcript. Key points from management (Nick Woodman and Brian McGee): - They discuss a multi-year TAM expanding strategy, initiated in May 2023. They mention retail channel unit sell-through growth of 25% from May to end of year, and overall unit sell-through up 3% from May 9th through end of 2023 vs prior year. They note that retail growth was offset by GoPro.com direct-to-consumer decline due to strategic decision to eliminate subscription-related camera discounts. They say "We believe our sell-through growth in retail gives us, and importantly gives our retailers and distributors, confidence to lean in as we look to launch a number of new products." They also mention adding 3,200 new retail doors since May 2023, ahead of target, and plan to add 7,000 more over next two years. - They talk about 2024 plans: four new camera SKUs, acquisition of Forcite Helmet Systems (announced in January, on track to close this quarter), and a tech-enabled motorcycle helmet market. They say "We are on track to close this acquisition this quarter and will share specifics about our product vision as we get closer to the expected launch of our first helmet in 2025." So that's not yet closed, not yet operating. - They discuss subscribers: closed 2023 with 2.5 million subscribers, 12% YoY growth. They mention retention rates improving, and new Quik desktop app and Premium+ tier launched yesterday. They expect subscribers to be between 2.5 and 2.6 million by end of 2024, 4% growth at high end. - They discuss Q4 revenue shortfall: $295M vs guidance $325M due to lower demand in North America, particularly December, and lower sales of HERO10 Black due to not discounting. But they say gross margin outperformed by 140 bps, and non-GAAP EPS $0.02. - For 2024, they guide Q1 gross margin 32.5%, improving to 35% in Q2/Q3, 37-38% in Q4, full year 35.5% +/- 50 bps, up from 32% in 2023. - In Q&A, Brian McGee says: "I think, first of all, we just guided for the first quarter. Obviously, you saw that in our prepared remarks. Our comment there though, that has nothing to do with sell-through, that's actually going pretty well.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
PRPH · Q1 2023 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES The transcript shows management explicitly framing the current market view as mismatched with the company's actual position: "Anybody that's focused on us for earnings, you invested or are following the wrong company," "we're not an earnings story this year," and "focus less on revenues and earnings. This is a transition year." They repeatedly contrast this with the multi-billion-dollar assets already built and operating, whose contributions are still ramping or largely ahead. Concrete already-real items with meaningful payoff still ahead include: - The manufacturing facility (already at capacity, running nearly 100% YoY growth, with $25M revenue target for 2024 constrained only by capacity expansion this year; estimated $70M valuation next year plus $40M working capital and tens of millions in equipment). - Nebula Genomics (already generating >100% YoY revenue growth via direct-to-consumer sales; in-house whole-genome processing and B2B ramp expected in H2 202 3, particularly Q4, after validations complete in a couple of months).
KEY · Q3 2022 → YESThe question is: Does management convey that OUTSIDERS ARE CURRENTLY UNDERWEIGHTING SOMETHING THE COMPANY HAS ALREADY DONE — and does management answer that gap by pointing to at least one CONCRETE, A...YES Management repeatedly frames its interest-rate-risk positioning as something that “sets Key apart” and creates “unique and significant upside” that is not yet reflected in the market’s view of the company. Chris Gorman states that the $1.2 billion annualized benefit from re-pricing existing short-term Treasuries and swaps “ even in the event that rates remain at current levels” will arrive over the next two years, and Don Kimble confirms the same mechanics and timing. The $9 billion in short-term Treasuries and $26 billion in swaps are already on the balance sheet; the contribution is simply not yet in the reported results.
KIM · Q2 2018 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES Management explicitly frames the public-private pricing disconnect as a gap in how the company is valued versus its actual assets and execution. They point to the already-completed Toys "R" Us liquidation process (22 boxes resolved into OpCo and PropCo leases, with seven OpCo leases already signed and seven PropCo under 18-24 month resolution) as a concrete, already-real item whose rent contribution is still largely ahead in the reported results, with the 70-80 bps impact on occupancy and same-site NOI expected to be recaptured in Q3 and beyond.